The First Pediatric Patients with Coronavirus Disease 2019 (COVID-19) in Japan: Risk of Co-Infection with Other Respiratory Viruses

Jpn J Infect Dis. 2020 Sep 24;73(5):377-380. doi: 10.7883/yoken.JJID.2020.181. Epub 2020 May 29.

Abstract

Coronavirus disease 2019 (COVID-19) is a severe infectious disease of the respiratory tract caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2, and has a high mortality rate. The disease emerged from Wuhan, China, in late 2019, and spread to Japan, including Hokkaido, in January 2020. In February 2020, 3 children were diagnosed with COVID-19 in Furano, Hokkaido, Japan. During this period, influenza and human metapneumovirus infections were prevalent among children in the Furano region. Two of the 3 patients experienced co-infection with other respiratory viruses, including influenza virus A or human metapneumovirus. To the authors' knowledge, the cases described in the present report were the first pediatric patients with COVID-19 in Japan. In children with COVID-19, the possibility of co-infection with other respiratory pathogens should be considered.

Keywords: COVID-19; SARS-CoV-2; children; co-infection; respiratory pathogens.

Publication types

  • Case Reports

MeSH terms

  • Betacoronavirus / isolation & purification
  • COVID-19
  • Child
  • Child, Preschool
  • Coinfection / diagnosis*
  • Coinfection / pathology
  • Coinfection / virology
  • Coronavirus Infections / diagnosis*
  • Coronavirus Infections / pathology
  • Coronavirus Infections / virology
  • Humans
  • Japan / epidemiology
  • Lung / diagnostic imaging
  • Lung / pathology
  • Male
  • Pandemics
  • Pneumonia, Viral / diagnosis*
  • Pneumonia, Viral / pathology
  • Pneumonia, Viral / virology
  • Respiratory Tract Infections / diagnosis*
  • Respiratory Tract Infections / pathology
  • Respiratory Tract Infections / virology
  • SARS-CoV-2